The AHA May 16 the Department of Commerce to consider tariff exceptions for critical minerals and derivative products used for medical purposes. Critical minerals have many medical uses, such as for magnetic resonance imaging, computerized tomography, positron emission tomography, radiopharmaceuticals and radiation therapy equipment.  
 
“Tariffs on critical minerals could have a particularly significant impact on complex medical devices that are higher cost and lower volume, in part due to requiring specialized parts and customization to meet the needs of health care providers,” the AHA wrote. “A recent survey found that 82% of health care experts expect tariff-related expenses to raise hospital costs by at least 15%, and 90% of supply chain professionals expect procurement disruptions. Given that hospital payments are set by government and private payer contracts, the costs would be borne by hospitals directly.” 

Related News Articles

Headline
The AHA May 14 urged the Senate Finance Committee to take steps to strengthen the supply chain for essential pharmaceutical and other medical products. In…
Headline
The U.S. and China reached a joint agreement to temporarily reduce tariffs for 90 days, the White House announced May 12. Both countries will lower tariffs by…
Headline
AHA today submitted comments to the Department of Commerce on its Section 232 national security investigation of pharmaceutical and pharmaceutical ingredients…
Headline
President Trump April 9 announced that reciprocal tariffs that went into effect after midnight for certain nations will be paused for 90 days, while tariffs…
Headline
The Food and Drug Administration March 14 released a notice on a nationwide shortage of hemodialysis tubes expected to last through early fall. On Jan. 8, B.…
Headline
The National Institutes of Health Feb. 7 issued supplemental guidance on updating negotiated indirect cost rates for new and existing NIH grants. The NIH will…